The Orreco platform. Image: Major League Soccer
Orreco uses AI, computer vision and biomarker data to optimise athlete performance, predict injury risk and accelerate recovery, according to the company.
Galway-based athletic bio-analytics company Orreco is to participate in the third edition of Major League Soccer (MLS)’s Innovation Lab, the North American professional football league’s initiative striving to advance the next generation of sports technology.
Orreco uses AI, computer vision and biomarker data to optimise athlete performance, predict injury risk and accelerate recovery, and is “trusted by elite teams and athletes across major leagues worldwide”, according to the company.
The programme cites key areas of focus in attempting to evolve technology around football as fan engagement, media technology and on-field development. MLS said it has chosen five AI-focused companies for the lab to “deploy solutions designed to address real challenges across the soccer ecosystem, creating a direct pathway from innovation to implementation”.
